Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes One RNAi-Related Patent Application: Jan 17, 2008

Premium
Title: Methods, Libraries, and Computer Program Products for Determining Whether siRNA-Induced Phenotypes are Due to Off-Target Effects
 
Number: 20080009012
 
Filed: July 6, 2007
 
Lead Inventor: Amanda Birmingham, Dharmacon (Thermo Fisher Scientific)
 
The patent application, its abstract states, claims “methods, libraries, and computer program products for determining whether a phenotype induced by a candidate siRNA for a target gene in an RNAi experiment is target specific or a false positive. Through the use of a control siRNA that has one or two seed sequences of six or seven bases in combination with a neutral scaffolding sequence, a distinction can be made between false positive and true positive analyses of functionality.”

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.